Haotian Yang

Dr. Haotian Yang

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
HYHaotian Yang
Haotian Yang
RVRehan M Villani
Rehan M Villani
HWHaolu Wang
Haolu Wang
MSMatthew J Simpson
Matthew J Simpson
Michael RobertsMichael Roberts
Michael Roberts
XLXiaowen Liang
Xiaowen Liang
Most chemotherapeutics elevate intracellular levels of reactive oxygen species (ROS), and many can alter redox-homeostasis of cancer cells. It is widely accepted that the anticancer effect of these chemotherapeutics is due to the induction of oxidative stress and ROS-mediated cell injury in cancer. However, various new therapeutic approaches targeting intracellular ROS levels have yielded mixed results. Since it is impossible to quantitatively detect dynamic ROS levels in tumors during and after chemotherapy in clinical settings, it is of increasing interest to apply mathematical modeling techniques to predict ROS levels for understanding complex tumor biology during chemotherapy. This review outlines the current understanding of the role of ROS in cancer cells during carcinogenesis and during chemotherapy, provides a critical analysis of the methods used for quantitative ROS detection and discusses the application of mathematical modeling in predicting treatment responses. Finally, we provide insights on and perspectives for future development of effective therapeutic ROS-inducing anticancer agents or antioxidants for cancer treatment.

20 November 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HWHaolu Wang
Haolu Wang
HYHaotian Yang
Haotian Yang
Zhi Ping XuZhi Ping Xu
Zhi Ping Xu
XLXin Liu
Xin Liu
Michael RobertsMichael Roberts
Michael Roberts
XLXiaowen Liang
Xiaowen Liang
A major impediment to the long-term in vivo vascular imaging is a lack of suitable probes and contrast agents. Our developed mercaptosuccinic acid (MSA) capped cadmium telluride/cadmium sulfide (CdTe/CdS) ultrasmall quantum dots (QDs) have high fluorescent quantum yield, long fluorescence lifetime and long half-life in blood, allowing high resolution long-term intravital vascular imaging. In this study, we showed that these QDs can be used to visualize the in vivo the vasculature in normal and cancerous livers in mice using multiphoton microscopy (MPM) coupled with fluorescence lifetime imaging (FLIM), with cellular resolution (~1 µm) up to 36 h after intravenous injection. Compared to highly regulated and controlled sinusoids in normal liver tissue, disordered, tortuous, and immature neovessels were observed in tumors. The utilized imaging methods have great potential as emerging tools in diagnosis and monitoring of treatment response in cancer.

12 June 2026 in Biomaterials
Verified
Journal Article
Open access
YXYan Xu
Yan Xu
ZTZhicheng Tong
Zhicheng Tong
XLXian'AN Li
Xian'AN Li
SYShuo Yang
Shuo Yang
QZQiuwen Zhu
Qiuwen Zhu
Hongwei WuHongwei Wu
Hongwei Wu
Patient-derived orthotopic xenotransplantation (PDOX) models have recently emerged as a potential approach for experimental therapeutics and precision medicine in malignant disease. However, the clinical application of PDOX models was restricted by the varying success rate of the animal models, long generation time, limited number of patient tumor cells and distinct stromal environments. To address this critical barrier, we developed an innovative patient-derived cell ring organoid platform using scaffold-free tumor cell rings. By co-culturing primary sarcoma cells with human skin fibroblasts (HSFs), functional tumor microenvironment (TME) -incorporated organoids were generated within 48 h without exogenous matrices. These organoids enabled rapid establishment of orthotopic xenografts (r-PDOX) in ≤7 days with 100% engraftment efficiency while requiring 50% fewer cells than conventional methods. Crucially, integrated HSFs replicated desmoplastic stroma and vascular networks, preserving patient-specific molecular profiles (transcriptomic correlation r = 0.87) and biological processes. As a preliminary proof-of-concept, the r-PDOX models showed encouraging concordance with patient responses to first-line therapeutics, including ifosfamide and anlotinib, though validation in larger cohorts is required. This platform overcomes key limitations of existing sarcoma models - including cell leakage, phenotypic drift, and protracted timelines, offering a physiologically relevant tool for personalized therapy exploration. The platform represents a promising methodological foundation for rapid sarcoma preclinical modeling in the era of precision oncology.

21 December 2022
Verified
Thesis
Closed access
HYHaotian Yang
Haotian Yang
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.